Artixio

Lifesciences Compliance Services in Philippines

Philippine market provides huge opportunities for enhancement of Lifesciences products. This facilitates manufacturers of Lifesciences product to thrive and expand with excellence in Philippines market.

Artixio as the trusted regulatory partner in Philippines helps in 100% regulatory compliance with the FDA Philippines. We focus on resolving regulatory concerns directly with the FDA Philippines for a hassle-free product approval and seamless regulatory process. Over the years we have supported products in Philippines with our experienced local professional in Philippines. We are committed in providing remarkable services to navigate through the challenges in Philippine compliance.

Regulatory Authorities in Philippines

The main regulatory authority governing in Philippines is the Food and Drug Administration (FDA) Philippines which was earlier known as the Bureau of Foods and Drugs. The FDA Philippines works under the Department of Health. Some other regulatory authorities are working too, such as Hong Kong’s Centre for Food Safety (CFS) which operates under the Hong Kong Food and Environmental Hygiene Department (FEHD) for regulation of beauty products and cosmetics, and the Bureau of Animal Industry (BAI) under the Philippine Department of Agriculture which regulates animal care and veterinary products.

The following table depicts the regulatory bodies responsible for which category of products:

Industry Regulatory Body Responsibilities
Pharmaceuticals FDA (Philippines) Grants drug approval and market access.
Ensures safety and efficacy of drug.
Medical Devices FDA (Philippines) Regulates the Medical devices in the Philippian market.
Wellness products CFS Confirms the quality and ensures the safety and efficacy of wellness products.
Cosmetics FDA (Philippines) Ensures the quality, standards, purity of cosmetics in Philippian market.
Animal care and Veterinary products BAI Regulates the veterinary products in the Philippian market by confirming its safety, efficacy and quality.

Ensure Seamless Regulatory Compliance in Philippines with Artixio

We provide end-to-end support to make your product reach heights of success in Philippines. We have a specialized team with local expertise that provides support for pharmaceuticals, medical devices, wellness products, animal care and veterinary products. We closely work with the FDA Philippines to address compliance doubts and queries, to guarantee a smooth hassle-free regulatory process that ultimately leads to a speedy product approval.

Service Category

Pre-registration services

Registration services

Post-registration services

Why Artixio?

Successful approvals and ongoing product lifecycle maintenance for 200+ products.
Diverse products experience across complex products categories and therapeutic areas.
Strong regional expertise, experts with 15-35 years of experience.
Proven experience in end-to-end product value chain from concept to commercialization.
TFDA experience in navigating through complex, often ambiguous regulations.
Intelligence driven, global regulatory services supported by Dvarka.
ISO 9001:2015 quality standards governed services.
Customer focused, flexible services and solutions.
Flexible business model including project based, managed services and FTE staffing model.
Hybrid-Local-Centralized support across all PMDA functions.

Our Services

Regulatory Affairs
Product Registration
Market Access
IND (Investigational New Drug)
NDA (New Drug Application)
Regulatory Operations
Technical Writing
Regulatory Strategy
Market Access

Industries We Serve in the Philippines

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

FAQs

Which is the reference drug authority in the Philippines?
The Philippine FDA is the main drug authority in Philippine who oversees the approval and ensures the safety, efficacy and quality of pharmaceuticals, cosmetics and medical devices. However, the animal care and veterinary products industry is overlooked by BAI while the wellness products are administered by CFS in Philippine. These authorities ensure the smooth working of regulations by the pharmaceuticals, medical devices, wellness products, animal care and veterinary industries.
The adverse drug reporting in Philippine is regulated by the Philippine FDA’s Centre for Drug Regulation and Research (CDRR). It has its online portal for reporting of adverse drug reactions known as the MedWatch program. The FDA’s form number 1576 is specifically designed for ADR reporting. It should be filled out electronically and submitted online or through email.
The fee’s structure varies from product to product depending upon the product and its category. Generally, the fees range from 10k-50k for pharmaceuticals, 5k-40k for medical devices.5k-10k for cosmetics, wellness products and animal care products.
The general timeline for the regulatory approval for pharmaceuticals, medical devices, wellness products, animal care and veterinary products is generally from few months to a year depending upon the product complexity such as pharmaceuticals may take longer time than nutraceuticals for their approval.
The foreign manufacturers need to appoint a local representative in the Philippine market for their products approval. The local agents are generally known as Authorized Representative (AR). The foreign manufacturer needs to submit carry the complete process through the AR. The AR is responsible for the filing the product approval application, submitting the necessary documents, ensuring regulatory compliance of the product, etc. He is also held responsible for the safety monitoring of the product after its approval.

Our Global Reach: Serving Life
Sciences Clients Worldwide

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

May 2, 2025
UK Releases Amendment & Guidance on Regulations in 2024 for Medical Devices (Post-market Surveillance Requirements)

UK Releases Amendment &

In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

April 23, 2025
Artixio Announces Grant for Early Stage Medtech Innovators as Part of MedTech InnovateIO Initiative

Artixio Announces Grant for

HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...

April 16, 2025